Testing JNJ-42756493 In Combination With Dexamethasone in Multiple Myeloma That Came Back After a Period of Improvement
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Evaluate Dara-CyBorD in Previously Untreated and Relapsed Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer Treatment
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study to Assess Disease Burden, in Terms of Health-related Quality of Life and Direct Healthcare Costs, in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Autologous Stem Cell Transplant (ASCT) in Spain
- Status
- COMPLETED
- Phase
- N/A
High Dose Carfilzomib for Newly Diagnosed Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study Testing Radium-223 Dichloride in Relapsed Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Ixazomib Rollover Study
- Status
- COMPLETED
- Phase
- PHASE2
A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use
- Status
- COMPLETED
- Phase
- N/A
A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
- Status
- COMPLETED
- Phase
- N/A
A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
- Status
- COMPLETED
- Phase
- N/A
A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- NA
Comparison of Geriatric Screening Methods in Newly Diagnosed Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- N/A
A Study of JNJ-54767414 (Daratumumab) in Combination With Lenalidomide and Dexamethasone in Japanese Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-dose Therapy and Autologous Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Prevalence of Ocular Disorders in Multiple Myeloma (MM-OO-16)
- Status
- COMPLETED
- Phase
- N/A
Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone in Chinese Patients With Relapsed and Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE3
PRospective Multiple Myeloma Impact Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pembrolizumab + Lenalidomide Post Autologous Stem Cell Transplant (ASCT) in High-risk Multiple Myeloma (MM)
- Status
- TERMINATED
- Phase
- PHASE2